{"url_path":"/sec/uthr/8-k/2026-06-29/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001104659-26-078865-index.html","accession_number":"0001104659-26-078865","cik":"0001082554","ticker":"UTHR","issuer_name":"UNITED THERAPEUTICS Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001104659-26-078865-index.html","primary_entity_key":"0001082554","primary_entity_name":"UNITED THERAPEUTICS Corp"},"word_count":85,"has_tables":true,"body_markdown":"Item 9.01.\nExhibits\n\n \n\n \n(d)  Exhibits\n\n \n \n \n \n\n \n**Exhibit No.**\n \n**Description of Exhibit**\n\n \n \n \n \n\n \n[10.1](tm2619258d1_ex10-1.htm)\n \n[United Therapeutics Corporation 2026 Stock Incentive Plan](tm2619258d1_ex10-1.htm)\n\n \n104\n \nThe cover page from this Current Report on Form 8-K, formatted in Inline XBRL\n\n \n\n3\n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \nUNITED THERAPEUTICS CORPORATION\n\n \n \n \n\nDated: June 29, 2026\nBy:\n/s/ Paul A. Mahon\n\n \nName:\nPaul A. Mahon\n\n \nTitle:\nGeneral Counsel\n\n \n\n4"}